Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$975,551
+$152,574 QoQ
Shares Held
2,694
+15.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,715
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. AMGN ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $975,551 | 2,694 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $822,977 | 2,339 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $764,268 | 2,335 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $700,984 | 2,484 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $739,348 | 2,648 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $791,960 | 2,542 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $680,009 | 2,609 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $905,732 | 2,811 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $875,172 | 2,801 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $810,312 | 2,850 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,154,960 | 4,010 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,094,121 | 4,071 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $963,566 | 4,340 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,049,195 | 4,340 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $952,857 | 3,628 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $850,434 | 3,773 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $964,197 | 3,963 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,087,706 | 4,498 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,033,287 | 4,593 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,100,038 | 5,173 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,273,106 | 5,223 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,314,463 | 5,283 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,351,009 | 5,876 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,586,466 | 6,242 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,524,834 | 6,465 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $581,632 | 2,869 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||